Promotor hypermethylated genes: prospective diagnostic biomarkers in oral cancerogenesis

Publication date: Available online 29 July 2018

Source: Journal of Cranio-Maxillofacial Surgery

Author(s): Suzana Dvojakovska, Danica Popovic-Monevska, Aleksandar Grcev, Goran Pancevski, Alberto Benedetti, Vladimir Popovski, Aleksandar Dimovski, Aleksandar Stamatoski

Abstract

The advancements in epigenetics of oral squamous cell carcinoma (OSCC), are made in regard to DNA hypermethylation of MGMT, DAPK, ECAD (E-cadherin) and p16, as an important component of oral carcinogenesis and new potential biomarkers in molecular diagnostic strategies. The objective of the study was to evaluate the methylation status of the proposed genes and their possible role in the tumor genesis and diagnosis of OSCC. Materials and methods: From sixty surgically treated and molecularly analyzed patients, we obtained three groups of bioptical materials: tumor, normal contralateral and healthy tissues. Comparison of the frequencies of DNA methylation for all transcripts was utilized to validated their potential role in the cancerogenesis and detection of OSCC. Results: The most often methylated genes in the tumor samples were ECAD, MGMT, DAPK followed by p16 genes (90% vs75% vs 75% vs 52,5%), respectively. We observed frequent methylated genes in contralateral mucosa and consistantly unmethylated- 0% in healthy samples. ECAD methylated genes showed the highest sensitivity for diagnosing OSCC in tumor and contralateral tissues (90% and 89,7% respectively, with a specificity of 100%). Conclusion: ECAD and MGMT have tumor-specific signatures and can be considered as potential noninvasive diagnostic biomarkers in OSCC.

https://ift.tt/2vcQdfH